Fig. 5From: Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: fueling or dampening disease progression?Hypothetically, LTB4/LTD4 can act as chemo-attractants through either the BLT-1 or CysLTR1 receptor on Th-17 lymphocytes thereby mediating their influx across the disrupted BBB towards high LTB4/LTD4 levels in the CNS of MS patientsBack to article page